The demand for Glucagon-like peptide-1 (GLP-1) agonists has significantly increased over the last few years, leading to the GLP-1 market’s projected growth to $71 billion in the next decade. This popularity can be attributed to the rising prevalence of diabetes and obesity in the United States, along with significant media attention.
What’s inside the Strategies for GLP-1 Management in Pharmacy Benefits eBook?
Truveris’ Strategies for GLP-1 Management in Pharmacy Benefits eBook is your guide to learning more about the GLP-1 market landscape, the impact to pharmacy program, and strategies for employers to manage the rising costs. In this eBook, we take a deep dive into the following areas:
- GLP-1 Market Landscape: Learn more about the drug class that has become a household name and is experiencing drug shortages due to demand. This section also takes a dive into the growing pipeline of GLP-1s as pharmaceutical manufacturers invest millions into R&D to increase indications and fill the demand for these drugs.
- Employer Considerations: Gain a clear understanding of the considerations employers need to keep in mind when planning for GLP-1 coverage. Covering these drugs can have a significant financial impact to employers.
- Strategies for GLP-1 Management: Learn about the various strategies that employers can implement to control costs when covering GLP-1s for their employees. This section also showcases a few examples of how employers are already navigating the financial impact of these drugs.
